Transparency of COVID-19 vaccine trials: decisions without data

Covid-19 vaccines: In the rush for regulatory approval, do we need more data?

(2021) Peter Doshi   BMJ-British Medical Journal

China is vaccinating a staggering 20 million people a day

(2021) Smriti Mallapaty   NATURE

Clinical trial publications: A sufficient basis for healthcare decisions?

(2020) Hans-Georg Eichler et al.   European Journal of Internal Medicine

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

(2020) Devan V. Mehrotra et al.   ANNALS OF INTERNAL MEDICINE

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

(2020) Shengli Xia et al.   LANCET INFECTIOUS DISEASES

Will covid-19 vaccines save lives? Current trials aren’t designed to tell us

(2020) Peter Doshi   BMJ-British Medical Journal

Covid-19 vaccine trial protocols released

(2020) Peter Doshi   BMJ-British Medical Journal

Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?

(2020) Raymond M Johnson et al.   BMJ-British Medical Journal

Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011

(2017) Peter Doshi et al.   JAMA Internal Medicine

Restoring invisible and abandoned trials: a call for people to publish the findings

(2013) P. Doshi et al.   BMJ-British Medical Journal

How to access and process FDA drug approval packages for use in research

(2013) E. H. Turner   BMJ-British Medical Journal

Why we need easy access to all data from all clinical trials and how to accomplish it

(2011) Peter C Gøtzsche   Trials